Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study

NCT04245644 · clinicaltrials.gov ↗

UNKNOWN

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Disease Free Survival
Overall Survival
Pancreatic Cancer

Interventions

BEHAVIORAL: use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins

Sponsor

Massimo Falconi